Some People Thought Donald Trump’s Approval Rating Would Have a Floor Around 40%. Well, it Didn’t
As war With Iran Drove oil Prices Higher, Trump Gave Politically Connected oil Companies — not Taxpayers — the Chance to Cash in on Publicly Owned oil
Five Questions the US Government Should Answer About Its Secretive Frontier AI Framework
The Cyclospora Mystery: How Human Poop Got on So Much Lettuce
Abortion Rates Were Expected to Tank After Roe v. Wade was Overturned. Instead, Medication Abortion Became Easy to get—and it Changed Everything
Under the Second Trump Administration, the Fight Over History has Become a Fight Over Democracy. Who Deserves to be Trusted With the Country’s Memory?
CBS News Reverses Course, Airs Story on 9/11 Families Supporting Mamdani
Defusing Misinformation Through Humor
The National Security Implications of Building Frontier AI Data Centers Overseas
The Self-Inflicted Decline of American Leadership
Some People Thought Donald Trump’s Approval Rating Would Have a Floor Around 40%. Well, it Didn’t
As war With Iran Drove oil Prices Higher, Trump Gave Politically Connected oil Companies — not Taxpayers — the Chance to Cash in on Publicly Owned oil
Five Questions the US Government Should Answer About Its Secretive Frontier AI Framework
The Cyclospora Mystery: How Human Poop Got on So Much Lettuce
Abortion Rates Were Expected to Tank After Roe v. Wade was Overturned. Instead, Medication Abortion Became Easy to get—and it Changed Everything
Under the Second Trump Administration, the Fight Over History has Become a Fight Over Democracy. Who Deserves to be Trusted With the Country’s Memory?
CBS News Reverses Course, Airs Story on 9/11 Families Supporting Mamdani
Defusing Misinformation Through Humor
The National Security Implications of Building Frontier AI Data Centers Overseas
The Self-Inflicted Decline of American Leadership

LeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

BURLINGTON, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will hold investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Tuesday, August 11, 2026.

About LeMaitre

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

Contact:
Sandra Millar
LeMaitre Vascular, Inc.
+1-781-425-1686
smillar@lemaitre.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.